VLPRAMQT

Product Name
VLPRAMQT
Product Quantity
4mg
Catalog Number
LT8274
Category
ARA70 Coactivator Peptide
Sequence
VLPRAMQT
Purity
>95%
Product Description

The peptide sequence VLPRAMQT corresponds to an 8-amino-acid fragment derived from the chicken interleukin-10 (IL-10) protein. This peptide has been identified as an immunogenic epitope and has been utilized in avian immunology research, particularly in the context of coccidiosis in poultry.

Role in IL-10 Neutralization: Interleukin-10 is an anti-inflammatory cytokine that plays a crucial role in regulating immune responses. In the context of Eimeria infections, which cause coccidiosis in poultry, IL-10 can suppress protective immune responses, leading to increased susceptibility to infection. To counteract this, researchers have developed strategies to neutralize IL-10 activity.

The VLPRAMQT peptide has generated specific antibodies against IL-10. By immunizing laying hens with this peptide conjugated to a carrier protein, researchers produced egg yolk-derived antibodies (IgY) that specifically bind to IL-10. These antibodies, when administered orally to broiler chickens, have been shown to mitigate the immunosuppressive effects of IL-10 during Eimeria infections, thereby improving growth performance and reducing disease severity.

Applications in Research and Poultry Health Vaccine Development: The VLPRAMQT peptide serves as a key component in developing oral vaccines aimed at enhancing resistance to coccidiosis by neutralizing IL-10.

Diagnostic Tools: This peptide has been utilized in enzyme-linked immunosorbent assays (ELISAs) to detect anti-IL-10 antibodies in egg yolk and plasma, facilitating the monitoring of immune responses in vaccinated birds.

Growth Performance Studies: Feeding broiler chickens with anti-IL-10 antibodies derived from VLPRAMQT-immunized hens has demonstrated improvements in weight gain and feed efficiency during Eimeria challenges.

The VLPRAMQT peptide is a significant tool in avian immunology research, particularly for its role in modulating immune responses during coccidiosis infections. Its application in generating specific anti-IL-10 antibodies offers a promising avenue for enhancing poultry health and performance.

Scientific Background

VLPRAMQT is a 8-residue synthetic peptide with the sequence Val-Leu-Pro-Arg-Ala-Met-Gln-Thr. The sequence has a relatively high hydrophobic-residue fraction that can influence aqueous solubility and surface adsorption. These sequence-derived properties describe the reagent chemically; no specific receptor, enzyme, pathway, disease association, or biological activity is assigned without product-specific experimental evidence.

Research Applications
  • LC-MS/HPLC analytical method development
  • sequence-specific assay controls
Experimental Notes

Sequence-derived chemical properties support reagent selection and experimental planning but do not establish biological function. Solubility, aggregation, adsorption, conjugation efficiency, and assay performance should be validated under the intended experimental conditions.

  • 5 Units in Stock
Ask a Question

$250.00

Add to Cart:

For more information, please visit this product's webpage.